Literature DB >> 712115

Reactogenicity and immunogenicity of whole and ether-Tween-split influenza A virus vaccines in volunteers.

R Jennings, A Clark, J S Oxford, D J Hockley, C W Potter.   

Abstract

Two separate, double-blind studies were carried out in volunteers to compare the reactogenicity of, and serum antibody responses to, whole or ether-Tween-split inactivated influenza virus vaccines. In both studies the ether-Tween-split vaccines induced a lower rate of reactions. The serum hemagglutination-inhibiting (HAI) antibody response of volunteers to the A/Scotland/74 component of the split vaccine used in the first study was significantly greater than that following inoculation of A/Scotland/74 whole-virus vaccine. The neuraminidase-inhibiting (NI) antibody responses of the volunteers to each vaccine were similar. In the second study, a markedly better NI antibody response to the influenza A virus component was seen following immunization with split-virus vaccine, but the HAI antibody response to both split and whole vaccines was the same. In both studies the serum HAI antibody responses to the B/Hong Kong/73 component of the vaccines were similar. Challenge of the volunteers with attenuated influenza viruses homologous to the influenza A component of the vaccines showed both types of vaccines to be protective.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 712115     DOI: 10.1093/infdis/138.5.577

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  Comparison of adverse reactions to whole-virion and split-virion influenza vaccines in hospital personnel.

Authors:  A al-Mazrou; D W Scheifele; T Soong; G Bjornson
Journal:  CMAJ       Date:  1991-08-01       Impact factor: 8.262

2.  Improved colorimetric assay for detecting influenza B virus neutralizing antibody responses to vaccination and infection.

Authors:  G A Tannock; J A Paul; R Herd; R D Barry; A L Reid; M J Hensley; R S Gillett; S M Gillett; P Lawrance; R L Henry
Journal:  J Clin Microbiol       Date:  1989-03       Impact factor: 5.948

3.  Antibody response and persistence in volunteers following immunization with varying dosages of a trivalent surface antigen influenza virus vaccine.

Authors:  R Jennings; T L Smith; A R Mellersh; A Clark; R C Spencer; C W Potter
Journal:  J Hyg (Lond)       Date:  1985-02

4.  Use of the enzyme-linked immunosorbent assay (ELISA) for the estimation of serum antibodies in an influenza virus vaccine study.

Authors:  R Jennings; T Smith; C W Potter
Journal:  Med Microbiol Immunol       Date:  1981       Impact factor: 3.402

5.  A graded-dose study of inactivated, surface antigen influenza B vaccine in volunteers: reactogenicity, antibody response and protection to challenge virus infection.

Authors:  A Goodeve; C W Potter; A Clark; R Jennings; G C Schild; R Yetts
Journal:  J Hyg (Lond)       Date:  1983-02

6.  A comparison of adverse effects of two influenza vaccines, and the influence on subsequent uptake.

Authors:  M P Ryan; A F MacLeod
Journal:  J R Coll Gen Pract       Date:  1984-08

7.  Responses of volunteers to inactivated influenza virus vaccines.

Authors:  R Jennings; C W Potter; P M Massey; B I Duerden; J Martin; A M Bevan
Journal:  J Hyg (Lond)       Date:  1981-02

8.  Transmissibility of influenza viruses in hamsters.

Authors:  M J Ali; C Z Teh; R Jennings; C W Potter
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

9.  A comparison of live and inactivated influenza A (H1N1) virus vaccines. 1. Short-term immunity.

Authors:  A Clark; C W Potter; R Jennings; J P Nicholl; A F Langrick; G C Schild; J M Wood; D A Tyrrell
Journal:  J Hyg (Lond)       Date:  1983-06

10.  Specificity and in vitro transfer of the immunosuppressive effect of detergent-disrupted influenza virus vaccine.

Authors:  T L Smith; R Jennings
Journal:  Clin Exp Immunol       Date:  1990-01       Impact factor: 4.330

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.